Table 2 Clinicopathologic characteristics of DHL/THL in GI.
Case # | Sex | Age (y) | Location | History (mo) | Timing of diagnosis | B symptoms | CNS involvement | Stage | Regimen for the first-line treatment | Survival after diagnosis (mo) | Current status | EBER | HBV infection status | Morphology | DHL/THL |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | F | 70 | Stomach | NA | Transformationa | No | No | III | R-CHOP | 43 | AWD | − | NHHI | D | D1 |
2 | M | 23 | Colon | 2 | De novo | Yes | No | IVA | CHOP | 37 | AWD | − | NHHI | D | D2 |
3 | F | 56 | Stomach | 1 | De novo | NA | No | IV | R-CHOP | 1 | DOD | NA | NA | D | D1 |
4 | F | 49 | Rectum | 1 | De novo | No | No | IV | R-CHOP | 6 | DOD | − | PHI | D | D1 |
5 | M | 42 | Small intestine | 3 | De novo | Yes | No | II | R-CHOP+HD-MTX+IT | 25 | AWD | − | NHHI | D | D2 |
6 | M | 57 | Stomach | 3 | NA | NA | NA | NA | NA | 2 | DOD | + | NA | D | D2 |
7 | M | 81 | Stomach | 1 | De novo | Yes | No | IV | NA | 2 | DOD | − | PHI | D | D2 |
8 | F | 59 | Stomach | 1 | De novo | Yes | No | IIE | DA-R-EPOCH +HD-MTX+IT | 9 | AWD | − | NHHI | D | THL |
9 | M | 82 | Small intestine | 5 | De novo | No | NA | IV | R+lenalidomide | 5 | AWD | + | PHI | B | D2 |
10 | F | 52 | Stomach | 6 | De novo | Yes | NA | IV | NA | 5 | DOD | − | NA | D | D2 |
11 | M | 47 | Stomach | 1 | De novo | Yes | NA | IV | NA | 1 | DOD | − | PHI | B | D1 |
12 | M | 46 | Colon | 1 | De novo | No | No | IV | R-CHOP-E | LFU | LFU | − | PHI | D | D1 |
13 | M | 48 | Caecum | 2 | NA | No | No | IVA | CHOP | 16 | AWD | − | NA | D | D1 |
14 | M | 62 | Jejunum | 6 | De novo | No | No | II | NA | 18 | AWD | − | PHI | D | D2 |
15 | F | 20 | Stomach | NA | NA | NA | NA | NA | NA | LFU | LFU | − | NA | D | D2 |
